alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     THIS  SCHEDULE  CONTAINS  SUMMARY  FINANCIAL   INFORMATION  EXTRACTED  FROM
     CONSOLIDATED  UNAUDITED  CONDENSED  FINANCIAL  STATEMENTS  FILED  WITH  THE
     COMPANY'S  SEPTEMBER  30,  1999,  QUARTERLY  REPORT ON FORM  10-QSB  AND IS
     QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK>                   0001036478
<NAME>                   NovaMed, Inc.
<MULTIPLIER>                                   1
<CURRENCY>                                    U.S. Dollars

<S>                             <C>
<PERIOD-TYPE>                                 9-Mos
<FISCAL-YEAR-END>                             Dec-31-1999
<PERIOD-START>                                Jan-1-1999
<PERIOD-END>                                  Sep-30-1999
<EXCHANGE-RATE>                                1
<CASH>                                           72,905
<SECURITIES>                                          0
<RECEIVABLES>                                   344,658
<ALLOWANCES>                                          0
<INVENTORY>                                     670,439
<CURRENT-ASSETS>                              1,088,439
<PP&E>                                           62,980
<DEPRECIATION>                                   18,400
<TOTAL-ASSETS>                                1,206,350
<CURRENT-LIABILITIES>                         1,034,464
<BONDS>                                               0
<PREFERRED-MANDATORY>                                 0
<PREFERRED>                                           0
<COMMON>                                         13,846
<OTHER-SE>                                      158,040
<TOTAL-LIABILITY-AND-EQUITY>                  1,206,350
<SALES>                                       1,304,638
<TOTAL-REVENUES>                              1,304,638
<CGS>                                           714,892
<TOTAL-COSTS>                                 2,088,198
<OTHER-EXPENSES>                               (100,963)
<LOSS-PROVISION>                                      0
<INTEREST-EXPENSE>                                    0
<INCOME-PRETAX>                                (682,963)
<INCOME-TAX>                                          0
<INCOME-CONTINUING>                            (682,963)
<DISCONTINUED>                                        0
<EXTRAORDINARY>                                       0
<CHANGES>                                             0
<NET-INCOME>                                   (682,963)
<EPS-BASIC>                                        (.05)
<EPS-DILUTED>                                      (.05)



</TABLE>
#### John M. Newton, as Trustee, etc., Respondent, v. William Reid, Appellant.

Order reversed, with ten dollars costs and printing disburse*645ments, and retaxation granted, with ten dollars costs, but plaintiff to lbe at liberty to apply to the court to ascertain value of real estate, and then to have proper statutory allowance computed by clerk. Mem. by

Learned, P. J.
Exhibit
32.2











CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO SECTION 906 OF


THE
SARBANES-OXLEY ACT OF 2002





In
connection with the filing of the Quarterly Report on Form 10-Q of South Jersey
Gas Company (the “Company”) for the period ended March 31, 2008, as filed with
the Securities and Exchange Commission on the date hereof (the “Report”), I,
David A. Kindlick, Chief Financial Officer of the Company, hereby certify
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:





(1)           The
Report fully complies with the requirements of Section 13(a) or Section 15(d) of
the Securities Exchange Act of 1934; and





(2)           The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.








/s/ David
A. Kindlick


-------------------------------------------------------


Name:
David A. Kindlick


Title:
Chief Financial Officer


May 13,
2008
<TABLE> <S> <C>

<ARTICLE> 9
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               MAR-31-1998
<CASH>                                               2
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                          0
<INVESTMENTS-CARRYING>                               0
<INVESTMENTS-MARKET>                                 0
<LOANS>                                         60,392
<ALLOWANCE>                                          0
<TOTAL-ASSETS>                                  60,861
<DEPOSITS>                                           0
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                                  5
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                     30,250
<COMMON>                                        30,250
<OTHER-SE>                                         356
<TOTAL-LIABILITIES-AND-EQUITY>                  60,861
<INTEREST-LOAN>                                  1,040
<INTEREST-INVEST>                                    0
<INTEREST-OTHER>                                     2
<INTEREST-TOTAL>                                 1,042
<INTEREST-DEPOSIT>                                   0
<INTEREST-EXPENSE>                                   0
<INTEREST-INCOME-NET>                            1,042
<LOAN-LOSSES>                                        0
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                     39
<INCOME-PRETAX>                                  1,003
<INCOME-PRE-EXTRAORDINARY>                       1,003
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,003
<EPS-PRIMARY>                                    10.14
<EPS-DILUTED>                                    10.14
<YIELD-ACTUAL>                                    7.53
<LOANS-NON>                                          0
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                     0
<CHARGE-OFFS>                                        0
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                                    0
<ALLOWANCE-DOMESTIC>                                 0
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        

</TABLE>
From: hmanheim@ec.rr.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 12:53:41 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

h manheim

Jacksonville, NC 28540
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET AT DECEMBER 31, 1997, AND THE STATEMENTS OF OPERATIONS FOR THE TWELVE
MONTHS ENDED DECEMBER 31, 1997 AND IS QUALIFIED FOR ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                         462,900
<SECURITIES>                                         0
<RECEIVABLES>                                  135,500
<ALLOWANCES>                                    28,000
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                      13,856,100
<DEPRECIATION>                              10,477,900
<TOTAL-ASSETS>                               4,696,000
<CURRENT-LIABILITIES>                        1,284,000
<BONDS>                                        250,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                 4,696,100
<SALES>                                              0
<TOTAL-REVENUES>                             5,369,200
<CGS>                                                0
<TOTAL-COSTS>                                4,056,600
<OTHER-EXPENSES>                             (237,100)
<LOSS-PROVISION>                               232,500
<INTEREST-EXPENSE>                             107,500
<INCOME-PRETAX>                              1,442,200
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          1,442,200
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,442,200
<EPS-PRIMARY>                                    47.69
<EPS-DILUTED>                                        0


</TABLE>
No. 552, Misc.

#### Patterson *v.*Maxwell, Warden.

Motion for leave to file petition for writ of habeas corpus and for other relief denied.
From: Susan Hunt

To: E-OHPSCA2713.EBSA

Subject: Thank you for supporting birth control access for all women

Date: Sunday, August 07, 2011 11:06:41 AM

Dear Kathleen Sebelius, Secretary of Health & Human Services,

I commend the Department of Health & Human Services' landmark decision requiring health insurers to

cover the full cost of contraception, with no co-pay, beginning in August 2012.

This policy places a much-needed importance on women's health that is too-often not a priority in

health care policy. Birth control is a critical part of preventive care, and making contraception available

to all women, regardless of their insurance or ability to pay for it, will significantly reduce long-term

health care costs associated with unplanned pregnancies.

Thank you for prioritizing women's basic health care needs.

Sincerely,

Susan Hunt

P. O. Box 600401

San Diego, CA 92160
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                         339,308
<SECURITIES>                                         0
<RECEIVABLES>                               55,964,151
<ALLOWANCES>                               (1,623,474)
<INVENTORY>                                  6,615,531
<CURRENT-ASSETS>                            87,908,963
<PP&E>                                     236,692,839
<DEPRECIATION>                            (49,401,742)
<TOTAL-ASSETS>                           1,666,580,720
<CURRENT-LIABILITIES>                      101,885,340
<BONDS>                                  1,039,843,580
<PREFERRED-MANDATORY>                      525,797,350
<PREFERRED>                                    314,286
<COMMON>                                           573
<OTHER-SE>                               (240,438,701)
<TOTAL-LIABILITY-AND-EQUITY>             1,666,580,720
<SALES>                                      9,952,331
<TOTAL-REVENUES>                           235,139,870
<CGS>                                       18,561,827
<TOTAL-COSTS>                              230,096,458
<OTHER-EXPENSES>                           (3,411,347)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                          82,364,725
<INCOME-PRETAX>                           (76,034,850)
<INCOME-TAX>                                28,891,955
<INCOME-CONTINUING>                       (47,142,895)
<DISCONTINUED>                            (41,811,237)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (88,954,132)
<EPS-BASIC>                                   (283.50)
<EPS-DILUTED>                                 (283.50)


</TABLE>
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF PAMECO CORPORATION FOR THE THREE MONTHS ENDED AUGUST 31,
1997, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          FEB-28-1998
<PERIOD-START>                             JUN-01-1997
<PERIOD-END>                               AUG-31-1997
<CASH>                                             130
<SECURITIES>                                         0
<RECEIVABLES>                                   35,609
<ALLOWANCES>                                     3,175
<INVENTORY>                                    100,242
<CURRENT-ASSETS>                               133,931
<PP&E>                                          10,574
<DEPRECIATION>                                   3,052
<TOTAL-ASSETS>                                 166,037
<CURRENT-LIABILITIES>                           79,368
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            87
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                   166,037
<SALES>                                        146,460
<TOTAL-REVENUES>                               146,460
<CGS>                                          112,078
<TOTAL-COSTS>                                  135,931
<OTHER-EXPENSES>                                   912
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  19
<INCOME-PRETAX>                                  9,598
<INCOME-TAX>                                     3,624
<INCOME-CONTINUING>                              5,974
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     5,974
<EPS-PRIMARY>                                     0.67
<EPS-DILUTED>                                     0.67
        

</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Center for Complementary and Integrative Health Special Emphasis Panel Early Phase Clinical Trials of Natural Products (NP).                    

*Date:*                         October 20, 2023.                    

*Time:*                         11:00 a.m. to 1:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Center for Complementary and Integrative Health Democracy II 6707 Democracy Blvd. Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Shiyong Huang, Ph.D., Scientific Review Officer, Office of Scientific Review, Division of Extramural Activities, NCCIH/NIH, 6707 Democracy Boulevard, Suite 401, Bethesda, MD 20817,                         *shiyong.huang@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.213, Research and Training in Complementary and Alternative Medicine, National Institutes of Health, HHS)

Dated: September 13, 2023.

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2023-20120 Filed 9-15-23; 8:45 am]

BILLING CODE 4140-01-P
[Federal Register Volume 88, Number 177 (Thursday, September 14, 2023)]
[Notices]
[Page 63148]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-19832]


-----------------------------------------------------------------------

POSTAL SERVICE


Product Change--Priority Mail and USPS Ground Advantage[supreg] 
Negotiated Service Agreement

AGENCY: Postal Service<SUP>TM</SUP>.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Postal Service gives notice of filing a request with the 
Postal Regulatory Commission to add a domestic shipping services 
contract to the list of Negotiated Service Agreements in the Mail 
Classification Schedule's Competitive Products List.

DATES: Date of required notice: September 14, 2023.

FOR FURTHER INFORMATION CONTACT: Sean Robinson, 202-268-8405.

SUPPLEMENTARY INFORMATION: The United States Postal Service[supreg] 
hereby gives notice that, pursuant to 39 U.S.C. 3642 and 3632(b)(3), on 
September 6, 2023, it filed with the Postal Regulatory Commission a 
USPS Request to Add Priority Mail & USPS Ground Advantage[supreg] 
Contract 50 to Competitive Product List. Documents are available at 
www.prc.gov, Docket Nos. MC2023-261, CP2023-264.

Sean Robinson,
Attorney, Corporate and Postal Business Law.
[FR Doc. 2023-19832 Filed 9-13-23; 8:45 am]
BILLING CODE 7710-12-P
**Exhibit 21.1**

 

 

**3COM CORPORATION SUBSIDIARIES**

 

3Com (Austria) GesmbH (Austria)

3Com (Schweiz) A.G. (Switzerland)

3Com (Thailand) Co. Ltd. (Thailand)

3Com (U.K.) Limited (United Kingdom)

3Com Asia Limited (Hong Kong)

3Com Asia Pacific Rim PTE Limited (Singapore)

3Com Australia Pty. Ltd. (Australia)

3Com Benelux B.V. (The Netherlands)

3Com Bilgisayer Ticaret A.S. (Turkey)

3Com Canada Inc. (Toronto)

3Com Capital Corporation (California, U.S.A.)

3Com de Chile S.A. (Chile)

3Com de Mexico, S.A. de C.V. (Mexico)

3Com Denmark AS (Denmark)

3Com do Brasil Servicos Ltda. (Brazil)

3Com Europe Limited (United Kingdom)

3Com GmbH (Germany)

3Com Holdings Limited (Cayman Islands)

3Com Holdings SAS (France)

3Com Hungary Kft (Hungary)

3Com Iberia S.A. (Spain)

3Com IFSC (Ireland) 

3Com India Pte. Ltd. (India)

3Com International (New Zealand) Limited (New Zealand).

3Com International, Inc. (Delaware, U.S.A.)

3Com Ireland Ltd. (Ireland)

3Com Ireland Technologies Limited (Cayman Islands)

3Com Israel Limited (Israel)

3Com Italia S.p.A. (Italy)

3Com Japan K.K. (Japan)

3Com Korea Limited (Korea)

3Com Nordic AB (Sweden)

3Com Pension Scheme (1996) Trustees Limited (United Kingdom)

3Com Philippines Inc. (Philippines)

3Com Polska sp. z.o.o. (Poland)

3Com S.A.S. (France)

3Com South Asia PTE. Ltd. (Singapore)

3Com Technologies (Cayman Islands)

3Com U.K. Holdings Limited (United Kingdom)

3Com Ventures, Inc. (Delaware, U.S.A.)

Chipcom KK Ltd. (Japan)

Lansource Technologies Company (Canada)

Lanworks Technologies Company (Canada)

OOO 3Kom (Russia)

Three C Morocco SARL (Morocco)

TippingPoint Holdings, Inc. (Delaware, U.S.A.)

TippingPoint Technologies, Inc. (Delaware, U.S.A.)

TippingPoint Technologies Canada Inc. (Canada)

TippingPoint Technologies Europe B.V. (Netherlands)

TippingPoint Technologies GmbH (Germany)

TippingPoint Technologies U.K. Ltd. (United Kingdom)

U.S. Robotics Holdings Europe B.V. (Netherlands)
*Pursuant to 5TH CIR. R. 47.5, the Court has determined that this opinion should not be

published and is not precedent except under the limited circumstances set forth in 5TH CIR.

UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 97-31110

IN THE MATTER OF: GRAND PALAIS 

RIVERBOAT, INC., CRESCENT CITY 

CAPITAL DEVELOPMENT CORP., and

CRESCENT CITY CAPITAL DEVELOPMENT

CORP. LIQUIDATION TRUST,

Debtors,

GRAND PALAIS LITIGATION TRUST;

CRESCENT CITY LIQUIDATION TRUST,

Appellants,

versus

NEW ORLEANS 2000 PARTNERSHIP,

Appellee.

Appeal from the United States District Court

for the Eastern District of Louisiana

(97-CV-1241)

August 7, 1998

Before POLITZ, Chief Judge, WIENER and DENNIS, Circuit Judges.

PER CURIAM:*
R. 47.5.4.

2

Grand Palais Litigation Trust and Crescent City Liquidation Trust appeal

an adverse judgment of the district court affirming a judgment of the bankruptcy

court. Having considered the briefs and oral arguments of counsel and pertinent

parts of the record, and essentially for the reasons assigned by the district court,

the judgment appealed is AFFIRMED.